A SYSTEMATIC JOURNAL REVIEW: IDENTIFYING THE MOST COMMON SITE AND THE MOSTLY SHOWN CLINICAL MANIFESTATION OF BRAIN MENINGIOMA

Authors

  • Alya Tanti Nurjanah Universitas Bumigora
  • Dina Qurratu Ainin Universitas Bumigora
  • Dinmas Arif Almamfaluthi Universitas Bumigora
  • I Gusti Ayu Diah Kusuma Wardani Universitas Bumigora
  • Dini Wurnaning Budi Universitas Bumigora
  • Made Bayu Sanjaya Sanjaya Universitas Bumigora
  • Evan Christian Sumarno Universitas Bumigora

DOI:

https://doi.org/10.36002/js.v5i1.5697

Keywords:

Meningioma, Brain tumor, Systematic review

Abstract

Meningioma is the most common primary intracranial tumor, originating from the meninges surrounding the brain and spinal cord. Although its exact etiology remains unclear, exposure to ionizing radiation, hormonal factors, and genetic predisposition are considered important risk factors. This systematic review aimed to identify the most common anatomical location and clinical manifestations of brain meningioma worldwide. A literature search was conducted in PubMed, MedLine, and ProQuest for studies published between 2015 and May 2025. Eligible studies included original research focusing on intracranial meningioma, while studies involving other central nervous system tumors or non-journal publications were excluded. Of 95 identified articles, 10 studies involving more than 500 patients met the inclusion criteria. The findings consistently demonstrated that supratentorial meningiomas were the most frequent, particularly those located at the convexity (30%) and parasagittal region (24%). The most common clinical presentation was nonspecific headache, followed by vomiting, decreased level of consciousness, and other neurological deficits depending on tumor location. These findings highlight that supratentorial meningiomas represent the predominant anatomical site and that nonspecific headache remains the most frequent presenting symptom, emphasizing the importance of early clinical recognition and neuroimaging evaluation.

References

Alruwaili, A. A., & De Jesus, O. (2023). Meningioma. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560538/

Buerki, R. A., Horbinski, C. M., Kruser, T., Horowitz, P. M., James, C. D., & Lukas, R. V. (2018). An overview of meningiomas. Future Oncology, 14(21), 2161–2177. https://doi.org/10.2217/fon-2018-0006

Chakravarthy, V., Kaplan, B., Gospodarev, V., Myers, H., De Los Reyes, K., & Achiriloaie, A. (2018). Houdini tumor: Case report and literature review of pregnancy-associated meningioma. World Neurosurgery, 114, e1261–e1265. https://doi.org/10.1016/j.wneu.2018.03.144

Felistia, Y., Amanda, N. F., Hendrawan, F., Susanto, N. H., Al Fauzi, A., & Miftahussurur, M. (2025). Incidence and clinicopathological features of meningioma at the National Brain Center Hospital in Indonesia. Surgical Neurology International, 16, 463. https://doi.org/10.25259/SNI_334_2025

Gallagher, M. J., Jenkinson, M. D., Brodbelt, A. R., Mills, S. J., & Chavredakis, E. (2016). WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant? Clinical Neurology and Neurosurgery, 141, 117–121. https://doi.org/10.1016/j.clineuro.2016.01.006

Gitto, L., Bolino, G., & Cina, S. J. (2018). Sudden unexpected deaths due to intracranial meningioma: Presentation of six fatal cases, review of the literature, and a discussion of the mechanisms of death. Journal of Forensic Sciences, 63(3), 947–953. https://doi.org/10.1111/1556-4029.13626

Gurcay, A. G., Bozkurt, I., Senturk, S., Kazanci, A., Gurcan, O. F., Turkoglu, O. F., & Beskonakli, E. (2018). Diagnosis, treatment, and management strategy of meningioma during pregnancy. Asian Journal of Neurosurgery, 13(1), 86–89. https://doi.org/10.4103/1793-5482.181115

Kong, X., Gong, S., Lee, I. T., & Yang, Y. (2018). Microsurgical treatment of parafalcine meningiomas: A retrospective study of 126 cases. OncoTargets and Therapy, 11, 5279–5285. https://doi.org/10.2147/OTT.S162274

Nigim, F., Wakimoto, H., Kasper, E. M., Ackermans, L., & Temel, Y. (2018). Emerging medical treatments for meningioma in the molecular era. Biomedicines, 6(3), Article 86. https://doi.org/10.3390/biomedicines6030086

Nowosielski, M., Galldiks, N., Iglseder, S., Kickingereder, P., von Deimling, A., Bendszus, M., Wick, W., & Sahm, F. (2017). Diagnostic challenges in meningioma. Neuro-Oncology, 19(12), 1588–1598. https://doi.org/10.1093/neuonc/nox101

Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology, 21(Suppl. 5), v1–v100. https://doi.org/10.1093/neuonc/noz150

Rosenblum, M. D. (2016). Tumor. Clinical Neurology and Neurosurgery, 141, 117–121.

Starr, C. J., & Cha, S. (2017). Meningioma mimics: Five key imaging features to differentiate them from meningiomas. Clinical Radiology, 72(9), 722–728. https://doi.org/10.1016/j.crad.2017.05.002

Zhao, P., Li, N., Cao, J., Lin, X., & Liang, C. (2017). Rhabdoid meningioma arising concurrent in pulmonary and intracranial with a rare malignant clinical progression: Case report and literature review. World Neurosurgery, 107, 1046.e17–1046.e22. https://doi.org/10.1016/j.wneu.2017.08.118

Downloads

Published

2026-04-13

How to Cite

Nurjanah, A. T., Ainin, D. Q., Almamfaluthi, D. A., Wardani, I. G. A. D. K., Budi, D. W., Sanjaya, M. B. S., & Sumarno, E. C. (2026). A SYSTEMATIC JOURNAL REVIEW: IDENTIFYING THE MOST COMMON SITE AND THE MOSTLY SHOWN CLINICAL MANIFESTATION OF BRAIN MENINGIOMA . JURNAL KESEHATAN, SAINS, DAN TEKNOLOGI (JAKASAKTI), 5(1), 223–234. https://doi.org/10.36002/js.v5i1.5697